To this aim, the study compared the mucosa-associated microbiota of UC patients with and without PSC according to the presence of the PTPN2 SNP, in reference to a control group, by analyzing mucosal biopsies from multiple intestinal locations from UC patients of the Swiss IBD Cohort (SIBDCS) and a (local) Bern cohort. The gene discussed is PTPN2; the disease is pancreatic serous cystadenoma.